Agios Pharmaceuticals
AGIO
AGIO
198 hedge funds and large institutions have $3.3B invested in Agios Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 92 increasing their positions, 44 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.51% less ownership
Funds ownership: 105.35% → 102.84% (-2.5%)
14% less call options, than puts
Call options by funds: $26M | Put options by funds: $30.4M
Holders
198
Holding in Top 10
4
Calls
$26M
Puts
$30.4M
Top Buyers
| 1 | +$59.7M | |
| 2 | +$59.6M | |
| 3 | +$48.4M | |
| 4 |
BlackRock
New York
|
+$46.8M |
| 5 |
PA
Perceptive Advisors
New York
|
+$43M |
Top Sellers
| 1 | -$51.9M | |
| 2 | -$17.2M | |
| 3 | -$14.4M | |
| 4 |
Alkeon Capital Management
New York
|
-$14.1M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$13.6M |